North Wales, PA, United States of America

Christine Dieckhaus

This inventor holds 3 USPTO granted patents. Top assignees: University of Virginia Patent Foundation, Merck + Co., Inc.. Active years: 2003-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Dieckhaus. Retrieved from https://idiyas.com/inventor/christine-dieckhaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2003-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Christine Dieckhaus: Revolutionizing Neurological Treatment

Introduction:

Christine Dieckhaus, a pioneering inventor based in North Wales, PA, has made significant contributions to the field of neurological treatment through her innovative patents. With a total of three patents to her name, Dieckhaus is known for her groundbreaking work in developing compounds for treating various neurological conditions.

Latest Patents:

Dieckhaus' latest patents include the development of 4-cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists. These compounds are highly effective as NMDA/NR2B antagonists, offering promising solutions for treating a range of neurological conditions such as pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, and ischemic brain injury. Another patent focuses on novel felbamate derivatives, designed to treat neurological diseases like epilepsy and minimize the toxicity associated with traditional therapies.

Career Highlights:

Having worked with esteemed institutions and companies, Dieckhaus has left a profound impact on the field of neurology. She has served at the University of Virginia Patent Foundation, where her innovative research paved the way for new treatment methodologies. Additionally, her tenure at Merck & Company, Inc. showcased her ability to translate cutting-edge research into tangible solutions for complex neurological disorders.

Collaborations:

Throughout her career, Dieckhaus has collaborated with industry experts such as Timothy L. MacDonald and Thomas Allen Miller. These collaborative efforts have fostered a dynamic exchange of ideas, leading to the development of novel compounds and treatment modalities for neurological diseases. Dieckhaus' collaborative spirit has truly elevated the standard of care in neurology.

Conclusion:

In conclusion, Christine Dieckhaus stands as a trailblazer in the field of neurological treatment, with her innovative patents reshaping the landscape of neurology. Her relentless pursuit of excellence and commitment to improving patient outcomes make her a notable figure in the realm of medical innovation. Dieckhaus' contributions continue to inspire future generations of inventors and researchers in the quest for enhanced neurological therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…